62M
0
Enveric inks $62M licensing deal for psilocin prodrug
0

Enveric inks $62M licensing deal for psilocin prodrug

Enveric Biosciences (NASDAQ: ENVB) agreed to license one of its experimental psychedelic drug candidates to MycoMedica Life Sciences in a deal worth as much ...

reviewer4you.com reviewer4you.com 12 November 2024
READ MORE +
0
Your Cart is empty!

It looks like you haven't added any items to your cart yet.

Browse Products
Powered by Caddy